COMMUNIQUÉS West-GlobeNewswire

VistaGen Therapeutics Reports Fiscal 2019 Second Quarter Financial Results
29/10/2018
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2018 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system (CNS) [...]
Alder BioPharmaceuticals® to Host Conference Call to Discuss Third Quarter 2018 Financial and Operating Results
29/10/2018
BOTHELL, Wash., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Assertio Therapeutics Announces the Appointment of Daniel A. Peisert as Senior Vice President and Chief Financial Officer; Current CFO Phil B. Donenberg to Retire November 30, 2018
29/10/2018
LAKE FOREST, Ill., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that Phillip B. Donenberg, Senior Vice President and Chief Financial Officer, will retire effective [...]
Pain Therapeutics Reports Third Quarter 2018 Financial Results
29/10/2018
- Phase IIa Study Initiation On-track for Q4 2018 - AUSTIN, Texas, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company, today reported financial results for the third [...]
GenMark Diagnostics Reports Third Quarter 2018 Results
29/10/2018
CARLSBAD, Calif., Oct. 29, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the [...]
Aclaris Therapeutics to Announce Third Quarter 2018 Financial Results on November 6, 2018
29/10/2018
WAYNE, Pa., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]
Nuvectra® Reports Third Quarter 2018 Financial Results
29/10/2018
Reports Record Algovita ® Sales of $12.5 million, Up 98% YoY PLANO, Texas, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial [...]
AxoGen, Inc. Reports 2018 Third Quarter Financial Results
29/10/2018
Q3 Revenue of $22.7 million, representing 41% growth over prior year; Management reiterates full year 2018 guidance and introduces 2019 guidance ALACHUA, Fla., Oct. 29, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: [...]
Clementia Announces Proposed Public Offering of Common Shares
29/10/2018
MONTREAL, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq: CMTA), a clinical-stage biopharmaceutical company innovating treatments for people with ultra-rare bone disorders and other diseases, [...]
Clementia annonce un projet d’émission publique d’actions ordinaires
29/10/2018
MONTRÉAL, 29 oct. 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ : CMTA), une société biopharmaceutique au stade clinique proposant des traitements novateurs pour les personnes atteintes de troubles [...]
Avance® Nerve Graft Receives Regenerative Medicine Advanced Therapy (RMAT) Designation
29/10/2018
RMAT Designation reinforces clinical significance of RANGER® registry data and acknowledges the unmet need for improved nerve repair solutions ALACHUA, Fla., Oct. 29, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN [...]
Alzheimer’s Foundation of America Encourages Individuals to Get a Free Memory Screening This November During Alzheimer’s Awareness Month
29/10/2018
NEW YORK, Oct. 29, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America (AFA) is encouraging individuals to be proactive about their brain health and wellness by getting a free, confidential memory screening [...]
BioSig Technologies to Present at the 4th Annual Dawson James Small Cap Growth Conference
29/10/2018
Santa Monica, CA, Oct. 29, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical device company developing a proprietary biomedical signal processing platform designed [...]
Medifirst Solutions Announces New Division for CBD Products
29/10/2018
Freehold, NJ, Oct. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared [...]
CFN Media Enhances Go-To Market Program for Pre-Public Cannabis Companies
29/10/2018
Seattle, WA, Oct. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”, “CannabisFN”), the leading agency and financial media network dedicated to the worldwide cannabis industry, today [...]
BLOCKStrain Addresses Cannabis Diversion & Inversion Challenges -- CFN Media
29/10/2018
SEATTLE, Oct. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Sanofi: Disclosure of trading in own shares
29/10/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
29/10/2018
Pièce jointe Reporting FR.pdf
Major shareholder notification – Marathon Asset Management LLP
29/10/2018
GN Store Nord has received information that Marathon Asset Management LLP has increased its holdings of GN shares. Marathon Asset Management LLP thereby holds more than 5% of the share capital and the voting rights. For [...]

Pages